<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000046697"><TermName>interleukin-4 PE38KDEL immunotoxin</TermName><TermPronunciation>(in-ter-LOO-kin ... IH-myoo-noh-TOK-sin)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. It is made by combining interleukin-4 with a bacterial toxin. Interleukin-4 PE38KDEL immunotoxin is a type of recombinant chimeric protein. Also called interleukin-4 PE38KDEL cytotoxin and NBI-3001.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000709945" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;interleukin-4 PE38KDEL immunotoxin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000709946" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;interleucina-4 PE30KDEL inmunotoxina&quot;" language="es" id="_4"/><SpanishTermName>interleucina-4 PE30KDEL inmunotoxina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Está hecha de una combinación de interleucina 4 con una toxina bacteriana. La interleucina-4 PE30KDEL inmunotoxina es un tipo de proteína quimérica recombinante. También se llama interleucina-4 PE38KDEL citotoxina y NBI-3001.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2007-04-06</DateLastModified></GlossaryTerm>
